Search

everythinglearnresearchcommunity

for

Search:↓

Genetic discoveries are leading to new treatments for alopecia areata.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

The document explains various skin conditions and their treatments.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

The hepatitis B vaccine did not cause hair loss in the tested mice.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.